Corrigendum: Computational Approach Towards Exploring Potential Anti-Chikungunya Activity of Selected Flavonoids

Scientific Reports 6: Article number: 2402710.1038/srep24027; published online: April132016; updated: May312016 The original version of this Article contained an error in the spelling of the author Esaki Muthu Shankar, which was incorrectly given as Shankar Esaki Muthu. This has now been corrected in the PDF and HTML versions of the Article.

[1]  Justin Jang Hann Chu,et al.  Inhibition of Chikungunya Virus Replication by Harringtonine, a Novel Antiviral That Suppresses Viral Protein Expression , 2012, Antimicrobial Agents and Chemotherapy.

[2]  Shu-Feng Zhou,et al.  Estimation of the binding modes with important human cytochrome P450 enzymes, drug interaction potential, pharmacokinetics, and hepatotoxicity of ginger components using molecular docking, computational, and pharmacokinetic modeling studies , 2015, Drug design, development and therapy.

[3]  Weifeng Shi,et al.  The Antiviral Effect of Baicalin on Enterovirus 71 In Vitro , 2015, Viruses.

[4]  M. Shukor,et al.  Flavonoid Analyses and Antimicrobial Activity of Various Parts of Phaleria macrocarpa (Scheff.) Boerl Fruit , 2011, International journal of molecular sciences.

[5]  P. K. Roy,et al.  Structural analysis and molecular docking of potential ligands with chorismate synthase of Listeria monocytogenes: a novel antibacterial drug target. , 2015, Indian journal of biochemistry & biophysics.

[6]  Robert A Copeland,et al.  Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists. , 2005, Methods of biochemical analysis.

[7]  B. Joseph,et al.  MECHANISTIC CHARACTERIZATION AND DESIGNING POSSIBLE MOLECULAR LIGAND INTERACTIONS WITH RDRP FROM CHIKV , 2013 .

[8]  P. Dhar,et al.  Epitope characterization and docking studies on Chikungunya viral Envelope 2 protein , 2015 .

[9]  Didem Deliorman Orhan,et al.  Antibacterial, antifungal, and antiviral activities of some flavonoids. , 2010, Microbiological research.

[10]  Adel A Rashad,et al.  Chikungunya virus: emerging targets and new opportunities for medicinal chemistry. , 2014, Journal of medicinal chemistry.

[11]  A. Yueh,et al.  Baicalin, a metabolite of baicalein with antiviral activity against dengue virus , 2014, Scientific Reports.

[12]  K. Kohli,et al.  Mechanism of action of flavonoids as anti-inflammatory agents: a review. , 2009, Inflammation & allergy drug targets.

[13]  S. Pollastri,et al.  Flavonoids as Antioxidants and Developmental Regulators: Relative Significance in Plants and Humans , 2013, International journal of molecular sciences.

[14]  S. Cherian,et al.  Antiviral Perspectives for Chikungunya Virus , 2014, BioMed research international.

[15]  M. Mezei,et al.  Molecular docking: a powerful approach for structure-based drug discovery. , 2011, Current computer-aided drug design.

[16]  H. Szatyłowicz.  Structural aspects of the intermolecular hydrogen bond strength: H‐bonded complexes of aniline, phenol and pyridine derivatives , 2008 .

[17]  P. Wong,et al.  Antiviral activity of four types of bioflavonoid against dengue virus type-2 , 2011, Virology Journal.

[18]  Haibo Yu,et al.  Discovery of in silico hits targeting the nsP3 macro domain of chikungunya virus , 2014, Journal of Molecular Modeling.

[19]  L. Bora.  Homology Modeling and Docking to Potential Novel Inhibitor for Chikungunya (37997) Protein nsP2 Protease , 2012 .

[20]  Abirami Natarajan,et al.  Molecular docking studies of (4Z, 12Z)-cyclopentadeca-4, 12-dienone from Grewia hirsuta with some targets related to type 2 diabetes , 2015, BMC Complementary and Alternative Medicine.

[21]  H. Patel,et al.  Exploring the polymerase activity of chikungunya viral non structural protein 4 (nsP4) using molecular modeling, epharmacophore and docking studies , 2012 .

[22]  R. Sathishkumar,et al.  Anti-chikungunya activity of luteolin and apigenin rich fraction from Cynodon dactylon. , 2015, Asian Pacific journal of tropical medicine.

[23]  Hui Wang,et al.  Antiviral activity of baicalin against influenza A (H1N1/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase , 2014, Archives of Virology.

[24]  J. Chu,et al.  Antiviral activity of silymarin against chikungunya virus , 2015, Scientific Reports.

[25]  M. Schubert-Zsilavecz,et al.  Differential antiviral and anti-inflammatory mechanisms of the flavonoids biochanin A and baicalein in H5N1 influenza A virus-infected cells. , 2013, Antiviral research.

[26]  T. Ahola,et al.  Therapeutics and vaccines against chikungunya virus. , 2015, Vector borne and zoonotic diseases.

[27]  Zhan-Qiu Yang,et al.  Antiviral Activity of Total Flavonoid Extracts from Selaginella moellendorffii Hieron against Coxsackie Virus B3 In Vitro and In Vivo , 2014, Evidence-based complementary and alternative medicine : eCAM.

[28]  Robert Powers,et al.  Application of NMR and molecular docking in structure-based drug discovery. , 2012, Topics in current chemistry.

[29]  Sumra Wajid Abbasi,et al.  Molecular docking studies for the identification of novel melatoninergic inhibitors for acetylserotonin-O-methyltransferase using different docking routines , 2013, Theoretical Biology and Medical Modelling.

[30]  Erik Serrao,et al.  Design and discovery of flavonoid-based HIV-1 integrase inhibitors targeting both the active site and the interaction with LEDGF/p75. , 2014, Bioorganic & medicinal chemistry.

[31]  F. Rey,et al.  Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography , 2010, Nature.

[32]  M. Mustafa,et al.  Antiviral Activity of Baicalein and Quercetin against the Japanese Encephalitis Virus , 2012, International journal of molecular sciences.